HCP - Healthpeak Properties, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
35.78
-0.93 (-2.53%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close36.71
Open0.00
Bid0.00 x 1800
Ask0.00 x 1800
Day's Range35.67 - 36.58
52 Week Range26.58 - 37.93
Volume4,488,534
Avg. Volume3,364,168
Market Cap18.145B
Beta (3Y Monthly)0.16
PE Ratio (TTM)20.83
EPS (TTM)1.72
Earnings DateOct 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est37.31
  • PR Newswire

    Healthpeak™ Announces Lease Amendment and Extension with Amgen in South San Francisco

    Healthpeak Properties, Inc. (NYSE: PEAK) announced today that it has executed a lease amendment and extension with Amgen at Healthpeak's Britannia Oyster Point ("BOP") campus in South San Francisco. The BOP campus consists of ten buildings totaling over 900,000 square feet of Class-A life sciences space directly adjacent to Healthpeak's transformative 1 million square foot development, The Cove at Oyster Point.

  • PR Newswire

    Healthpeak™ Prices Public Offering of 15,000,000 Shares of Common Stock on a Forward Basis

    IRVINE, Calif., Nov. 4, 2019 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: HCP, to become "PEAK" effective November 5, 2019) ("Healthpeak") announced today the public offering of 15,000,000 shares of its common stock at a price of $35.00 per share in connection with its agreement to sell its common stock pursuant to the forward sale agreement described below. The underwriters have been granted a 30-day option to purchase up to an additional 2,250,000 shares of Healthpeak's common stock. BofA Securities and Morgan Stanley are acting as lead book-runners, and Barclays and Goldman Sachs are acting as additional book-runners for this offering.

  • PR Newswire

    Healthpeak™ Announces Public Offering of Common Stock on a Forward Basis

    IRVINE, Calif., Nov. 4, 2019 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: HCP, to become "PEAK" effective November 5, 2019) ("Healthpeak") announced today that it has commenced a public offering of an aggregate of 15,000,000 shares of its common stock in connection with the forward sale agreement described below. The underwriters are expected to be granted a 30-day option to purchase up to an additional 2,250,000 shares of Healthpeak's common stock. BofA Securities and Morgan Stanley are acting as joint book-runners for this offering.

  • Zacks

    HCP Tops Q3 FFO Estimate, Changes Name to Healthpeak Properties

    HCP, now renamed Healthpeak Properties, puts up an impressive show in third-quarter 2019 on the back of growth in the life-science and medical-office segments' net operating income.

  • MGP vs. HCP: Which Stock Is the Better Value Option?
    Zacks

    MGP vs. HCP: Which Stock Is the Better Value Option?

    MGP vs. HCP: Which Stock Is the Better Value Option?

  • HCP (HCP) Q3 FFO and Revenues Surpass Estimates
    Zacks

    HCP (HCP) Q3 FFO and Revenues Surpass Estimates

    HCP (HCP) delivered FFO and revenue surprises of 2.33% and 5.82%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • PR Newswire

    Healthpeak™ Reports Third Quarter 2019 Results

    IRVINE, Calif. , Oct. 30, 2019 /PRNewswire/ -- Healthpeak Properties, Inc., formerly known as HCP, Inc. (NYSE: HCP, to become "PEAK" effective November 5, 2019 ), today announced results for ...

  • PR Newswire

    HCP Changes Name to Healthpeak Properties™ and Announces Promotion of Scott Brinker to President and Chief Investment Officer Along with Other Leadership Promotions

    IRVINE, Calif., Oct. 30, 2019 /PRNewswire/ -- HCP, Inc. (HCP) announced today that it has changed its name to Healthpeak Properties, Inc. ("Healthpeak"), effective today. Healthpeak's common stock is expected to begin trading under its new name and ticker symbol "PEAK" on the New York Stock Exchange at the opening of trading on November 5, 2019. "Changing our name to Healthpeak Properties represents the culmination of efforts to reposition our strategy, team, portfolio and balance sheet," said Tom Herzog, Healthpeak's Chief Executive Officer.

  • Alexandria (ARE) Q3 FFO Meets Estimates, Rental Rate Grows
    Zacks

    Alexandria (ARE) Q3 FFO Meets Estimates, Rental Rate Grows

    Alexandria Real Estate Equities' (ARE) Q3 results reflect decent internal and external growth, as well as continued strong leasing activity and rental-rate growth in the quarter.

  • Will Growth in Seniors Housing Market Aid HCP's Q3 Earnings?
    Zacks

    Will Growth in Seniors Housing Market Aid HCP's Q3 Earnings?

    While HCP's Q3 results will likely reflect benefits of higher occupancy in the U.S. seniors housing market, a decline in income from direct financing lease might have impacted its revenue growth.

  • Does HCP, Inc.'s (NYSE:HCP) CEO Pay Compare Well With Peers?
    Simply Wall St.

    Does HCP, Inc.'s (NYSE:HCP) CEO Pay Compare Well With Peers?

    In 2017 Tom Herzog was appointed CEO of HCP, Inc. (NYSE:HCP). First, this article will compare CEO compensation with...

  • HCP Declares Quarterly Cash Dividend on Common Stock
    PR Newswire

    HCP Declares Quarterly Cash Dividend on Common Stock

    IRVINE, Calif. , Oct. 23, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) announced today that its Board of Directors declared a quarterly common stock cash dividend of $0.37 per share.  The dividend will be ...

  • HCP, Inc. (HCP): Hedge Fund Sentiment Unchanged
    Insider Monkey

    HCP, Inc. (HCP): Hedge Fund Sentiment Unchanged

    There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Jeff Ubben, George Soros and Carl Icahn think. Those hedge fund operators make billions of […]

  • Benzinga

    JPMorgan: REITs 'Set Up Well In This Environment'

    It’s been a good year for real estate investments, but one Wall Street analyst said Tuesday that there’s even more upside ahead. The Analyst JPMorgan analyst Michael Mueller made the following adjustments ...

  • HCP to Report Third Quarter 2019 Financial Results and Host Conference Call/Webcast
    PR Newswire

    HCP to Report Third Quarter 2019 Financial Results and Host Conference Call/Webcast

    IRVINE, Calif. , Oct. 3, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) is scheduled to report its third quarter 2019 financial results after the close of trading on the New York Stock Exchange on Wednesday, ...

  • Schaeffer's Investment Research

    5 REIT Stocks for Your Short-Term Watchlist

    RBC said the sector could be attractive to traders looking to play defense

  • HCP Announces Strategic Portfolio Trades With Brookdale
    Zacks

    HCP Announces Strategic Portfolio Trades With Brookdale

    HCP's mutually-beneficial agreement with Brookdale reduces the operator's concentration in the company's portfolio to 8% and enables transitions to Life Care Services under a highly-incentivized contract.

  • HCP Upgraded by Fitch Ratings to BBB+ with Stable Outlook
    PR Newswire

    HCP Upgraded by Fitch Ratings to BBB+ with Stable Outlook

    IRVINE, Calif. , Oct. 1, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) today announced that Fitch Ratings ("Fitch") upgraded HCP's corporate credit rating to BBB+ from BBB, with a stable outlook. ...

  • HCP Announces Series of Mutually Beneficial Transactions with Brookdale
    PR Newswire

    HCP Announces Series of Mutually Beneficial Transactions with Brookdale

    IRVINE, Calif., Oct. 1, 2019 /PRNewswire/ -- HCP, Inc. (HCP) today announced several transactions with Brookdale Senior Living Inc. ("Brookdale") related to HCP's 15-campus CCRC JV and triple-net portfolio with Brookdale that will position HCP to: (i) improve operator diversification, (ii) acquire Brookdale's interest in 12 CCRC campuses and (iii) strengthen the remaining Brookdale triple-net portfolio.

  • Should You Be Adding HCP (NYSE:HCP) To Your Watchlist Today?
    Simply Wall St.

    Should You Be Adding HCP (NYSE:HCP) To Your Watchlist Today?

    For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

  • Encouraging Near-Term Outlook for Equity REIT Stocks
    Zacks

    Encouraging Near-Term Outlook for Equity REIT Stocks

    Encouraging Near-Term Outlook for Equity REIT Stocks

  • Moody's

    HCP, Inc. -- Moody's assigns P-2 rating to HCP's new commercial paper program and affirms existing ratings

    Moody's Investors Service ("Moody's") has assigned a Prime-2 (P-2) short-term rating to HCP, Inc's $1 billion senior unsecured commercial paper (CP) program in the U.S. Concurrently, Moody's also affirmed all existing ratings of HCP, including its Baa1 senior unsecured debt rating. HCP's P-2 short-term rating reflects the healthcare REIT's strong liquidity position supported by its large unsecured revolving credit facility with a total capacity of $2.5 billion. The CP notes will be issued by HCP, Inc. and rank pari-passu with the REIT's other unsecured senior debt.

  • HCP Announces $1 Billion Commercial Paper Note Program
    PR Newswire

    HCP Announces $1 Billion Commercial Paper Note Program

    IRVINE, Calif., Sept. 18, 2019 /PRNewswire/ -- HCP, Inc. (HCP) announced today that it has established an unsecured commercial paper program (the "Commercial Paper Program"). Under the terms of the Commercial Paper Program, HCP may issue, from time to time, unsecured short-term debt securities with varying maturities not in excess of 397 days from the date of issue (the "Notes").  Amounts available under the Commercial Paper Program may be borrowed, repaid and re-borrowed from time to time, with the maximum aggregate face or principal amount of Notes outstanding at any one time not exceeding $1.0 billion. The proceeds of the Notes will be used for general corporate purposes.  HCP expects to use its revolving credit facility as a liquidity backstop for the repayment of the Notes issued under the Commercial Paper Program.

  • HCP to Buy Life Science Asset, Boost West Cambridge Cluster
    Zacks

    HCP to Buy Life Science Asset, Boost West Cambridge Cluster

    Delivering on its strategy to expand presence in the Boston region, HCP will acquire a trophy life science property -- 35 CambridgePark Drive -- for $332.5 million.